News
Good News for ALL Practices Nexplanon now Attracts an Administration Fee
UPDATE from Dispex 25th October 2024 By Dr Philip Koopowitz – Dispex & Hexagon6 Following clarification from NHSBSA, the reclassification of Nexplanon as “Attracts an Administration Fee” only comes into...
New Resources
PRINTED Copies Of The Dispensary Manager’s Guide At last month’s DDA conference, we presented the first printed copy, and delegates expressed a preference for being able to hold a physical version...
Another slap in the face for Dispensing Practices -Dispensing Fee Scale
By Dr Philip Koopowitz – Dispex & Hexagon6 The Dispensing Fee Scale from 1st October 2024 has been published and will impose a miniscule reduction in the Dispensing Fees. This...
Class 4 Medicines Defect Information: Sandoz Ltd., Linezolid 600 mg film-coated tablets, EL(24)A/48
Source: MHRA/Gov.uk 10.10.24 Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for Linezolid 600...
PRINTED Copies Of The Dispensary Manager’s Guide
At last month’s DDA conference, we presented the first printed copy, and delegates expressed a preference for being able to hold a physical version and flip through the pages. Get...
Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Ltd Cyanocobalamin 50 mcg Tablets, EL(24)A/46
Source: MHRA/Gov.uk 3.10.24 Glenmark Pharmaceuticals Europe Ltd is recalling the affected batches as a precautionary measure due to out of specification results for unknown impurities during routine stability testing and...
How to Access The Essential Dispensary Manager’s Guide
Exclusive Members’ Resource The Essential Dispensary Manager’s Guide is your comprehensive resource for mastering the art of dispensary management. Drawing on years of industry expertise and practical experience, this guide...
Class 4 Medicines Defect Information: Sandoz Ltd., Rosuvastatin 20mg, 40mg Tablets, EL(24)A/45
Source: MHRA/Gov.uk 1.10.24 Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for Rosuvastatin 20mg...
FREE Bite-Sized Educational Videos
NEW Feature for Members! We understand how busy practices are and that we all have different learning preferences. We already offer many different forms to help meet those different training...
Dispensary Profitability Review
Normally, our consultant will spend about 2 hours in the dispensary, observing and asking questions. He will look at processes and potential efficiencies. Our consultant will then need to spend...
What is Dispex AI?
All the power of Ankit AI but for Dispensing Teams. Answers typically in under 3 seconds. Using Dispex’s database to provide answers. Members can login here to access -the chatbot...
Class 2 Medicines Recall: Pfizer Limited, Oxbryta 500mg Tablets (voxelotor), EL(24)A/44
Source: MHRA/ Gov.uk 30.9.24 Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to...
